Chinese english Japanese Germany Korea
ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Cabozantinib impurity DX2

Cabozantinib impurity DX2

Cabozantinib impurity DX2 Structure
CAS No.
1628530-38-0
Chemical Name:
Cabozantinib impurity DX2
Synonyms
Cabozantinib Impurity 78;Cabozantinib impurity 65;Cabozantinib impurity DX2;Cabozantinib Metabolite M9;Tributyl Acetylcitrate Impurity 1 (Tributyl Acetylcitrate EP Impurity A);N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity）
CBNumber:
CB55590037
Molecular Formula:
C28H24FN3O6
Molecular Weight:
517.51
MOL File:
1628530-38-0.mol
Modify Date:
2023/5/15 10:43:29
Request For Quotation

Cabozantinib impurity DX2 Properties

Boiling point 781.8±60.0 °C(Predicted)
Density 1.447±0.06 g/cm3(Predicted)
pka 8.42±0.40(Predicted)

Cabozantinib impurity DX2 Preparation Products And Raw materials

Raw materials

Preparation Products

Cabozantinib impurity DX2 Suppliers

Global( 15)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Hubei Yangxin Medical Technology Co., Ltd. 15374522761 China 8366 55 Inquiry
Bide Pharmatech Ltd. 400-6005915 China 39668 58 Inquiry
Shanghai Jieshikai Biotechnology Co. , Ltd. 021-57520305 15801958784 China 49242 58 Inquiry
QUALITY CONTROL SOLUTIONS LTD. 0755-66853366; 13670046396 China 18899 58 Inquiry
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656 China 9911 50 Inquiry
Wuhan Yuxiang Medical Technology Co., Ltd. 13971275651 China 5201 58 Inquiry
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725 China 39990 58 Inquiry
Bide Pharmatech Ltd. 400-1647117 13681763483 China 62163 58 Inquiry
TargetMol Chemicals Inc. 4008200310 China 24647 58 Inquiry
Supplier Advantage
CLEARSYNTH LABS LTD. 58
Hubei Yangxin Medical Technology Co., Ltd. 55
Bide Pharmatech Ltd. 58
Shanghai Jieshikai Biotechnology Co. , Ltd. 58
QUALITY CONTROL SOLUTIONS LTD. 58
Shanghai Kewel Chemical Co., Ltd. 50
Wuhan Yuxiang Medical Technology Co., Ltd. 58
Shanghai Haohong Scientific Co., Ltd. 58
Bide Pharmatech Ltd. 58
TargetMol Chemicals Inc. 58

1628530-38-0(Cabozantinib impurity DX2)Related Search:

4-Aminoveratrole Cabozantinib Impurity 5 N-(4-fluorophenyl)-N-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide 4-chloro-6,7-dimethoxyquinoline Cabozantinib Impurity EXA
1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid Cyclopropanecarboxylic acid, 1-[[[4-[[7-methoxy-6-(sulfooxy)-4-quinolinyl]oxy]phenyl]amino]carbonyl]- 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl- Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-
Cabozantinib Malate 1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]- Cabozantinib Impurity DM 1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl-
N,N'-Bis(4-hydroxyphenyl)hydrazine N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Cabozantinib impurity 1DYH
chevron_left

1of4

chevron_right
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Cabozantinib impurity DX2 Cabozantinib impurity 65 1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)- N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide Cabozantinib Metabolite M9 Cabozantinib Impurity 78 Tributyl Acetylcitrate Impurity 1 (Tributyl Acetylcitrate EP Impurity A) N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity） 1628530-38-0